D. Hogue

A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer

B. Czerniecki, B. Niell, S. Hoover, 2020, Clinical Cancer Research.

A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer

D. Boulware, M. Extermann, H. Khong, 2019, The oncologist.

Quantitative assessment of new MRI-based measurements to differentiate low and high stages of pelvic organ prolapse using support vector machines

A. Weitzenfeld, S. Onal, S. Lai-Yuen, 2015, International Urogynecology Journal.

Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial

B. Czerniecki, B. Niell, S. Hoover, 2023, Nature Medicine.